Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:26 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | ARMISTICE CAPITAL LLC | 2,064,000 9.8% | -14,000 (-0.67%) | View |
| 2024-02-13 5:04 pm Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | VANGUARD GROUP INC | 1,793,786 8.52% | 271,597 (+17.84%) | View |
| 2024-01-26 09:11 am Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | Farallon Capital Partners L.P. | 2,025,000 9.6% | 475,000 (+30.65%) | View |
| 2024-01-24 5:23 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | BlackRock Inc. BLK | 1,934,711 9.2% | -43,300 (-2.19%) | View |
| 2024-01-22 12:25 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | STATE STREET CORP STT | 425,640 2.02% | -1,086,552 (-71.85%) | View |
| 2024-01-11 4:15 pm Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | MILLENNIUM MANAGEMENT LLC | 1,314,949 6.2% | 290,273 (+28.33%) | View |
| 2023-11-16 4:31 pm Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | MILLENNIUM MANAGEMENT LLC | 1,024,676 4.9% | 1,024,676 (New Position) | View |
| 2023-10-06 2:34 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | BlackRock Inc. BLK | 1,978,011 9.4% | -1,775,064 (-47.30%) | View |
| 2023-02-14 2:31 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | FIRST MANHATTAN CO. LLC. | 243,718 1.17% | -865,118 (-78.02%) | View |
| 2023-02-14 12:39 pm Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | ARMISTICE CAPITAL LLC | 2,078,000 9.99% | 1,022,000 (+96.78%) | View |
| 2023-02-09 11:19 am Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | VANGUARD GROUP INC | 1,522,189 7.32% | -103,720 (-6.38%) | View |
| 2023-02-08 1:17 pm Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | STATE STREET CORP STT | 1,512,192 7.27% | 385,123 (+34.17%) | View |
| 2023-02-06 09:06 am Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | Farallon Capital Partners L.P. | 1,550,000 7.5% | 1,550,000 (New Position) | View |
| 2023-01-31 3:17 pm Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | BlackRock Inc. BLK | 3,753,075 18% | 281,660 (+8.11%) | View |
| 2022-02-14 6:31 pm Unchanged | 13G | ENANTA PHARMACEUTICALS INC ENTA | ARMISTICE CAPITAL LLC | 1,056,000 5.1% | 0 (Unchanged) | View |
| 2022-02-14 6:18 pm Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | FIRST MANHATTAN CO. LLC. | 1,108,836 5.46% | 343,268 (+44.84%) | View |
| 2022-02-14 5:14 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | ARMISTICE CAPITAL LLC | 1,056,000 5.1% | -300,000 (-22.12%) | View |
| 2022-02-11 1:08 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 7.7% | -201,171 (-11.33%) | View |
| 2022-02-11 11:11 am Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | STATE STREET CORP STT | 1,127,069 5.55% | -46,171 (-3.94%) | View |
| 2022-02-10 6:09 pm Sale | 13G | ENANTA PHARMACEUTICALS INC ENTA | RENAISSANCE TECHNOLOGIES LLC | 714,400 3.48% | -319,500 (-30.90%) | View |